Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Clinical Trials as Topic. Found 30 abstracts

no pagination
Bauman JE, Cohen E, Ferris RL, Adelstein DJ, Brizel DM, Ridge JA, O'Sullivan B, Burtness BA, Butterfield LH, Carson WE, Disis ML, Fox BA, Gajewski TF, Gillison ML, Hodge JW, Le QT, Raben D, Strome SE, Lynn J, Malik S. Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting. Cancer. 2017 Apr;123(7):1259-71.   PMCID: PMC5705038
Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman J, Chirieac LR, D'Amico TA, Decamp MM, Dilling TJ, Dobelbower M, Doebele RC, Govindan R, Gubens MA, Hennon M, Horn L, Komaki R, Lackner RP, Lanuti M, Leal TA, Leisch LJ, Lilenbaum R, Lin J, Loo BW, Martins R, Otterson GA, Reckamp K, Riely GJ, Schild SE, Shapiro TA, Stevenson J, Swanson SJ, Tauer K, Yang SC, Gregory K, Hughes M. Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network. 2017 Apr;15(4):504-35.
Sato T, Issa JJ, Kropf P. DNA Hypomethylating Drugs in Cancer Therapy. Cold Spring Harbor perspectives in medicine. 2017 May;7(5).   PMCID: PMC5411681
Bass SB, Wolak C, Greener J, Tedaldi E, Nanavati A, Ruppert K, Gordon TF. Using perceptual mapping methods to understand gender differences in perceived barriers and benefits of clinical research participation in urban minority HIV+ patients. AIDS Care. 2016 Nov 17;28(4):528-36.
Bass SB, Wolak C, Greener J, Tedaldi E, Nanavati A, Ruppert K, Gordon TF. Using perceptual mapping methods to understand gender differences in perceived barriers and benefits of clinical research participation in urban minority HIV+ patients. AIDS Care. 2016 Jan;28(4):528-36.
Meropol NJ, Wong YN, Albrecht T, Manne S, Miller SM, Flamm AL, Benson AB, Buzaglo J, Collins M, Egleston B, Fleisher L, Katz M, Kinzy TG, Liu TM, Margevicius S, Miller DM, Poole D, Roach N, Ross E, Schluchter MD. Randomized Trial of a Web-Based Intervention to Address Barriers to Clinical Trials. J Clin Oncol. 2016 Feb 10;34(5):469-78.   PMCID: PMC4872012
Wong YN, Schluchter MD, Albrecht TL, Benson AB, Buzaglo J, Collins M, Flamm AL, Fleisher L, Katz M, Kinzy TG, Liu TM, Manne S, Margevicius S, Miller DM, Miller SM, Poole D, Raivitch S, Roach N, Ross E, Meropol NJ. Financial Concerns About Participation in Clinical Trials Among Patients With Cancer. J Clin Oncol. 2016 Feb 10;34(5):479-87.   PMCID: PMC4872013
Bhatia A, Burtness B. Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials. J Clin Oncol. 2015 Oct 10;33(29):3243-50.   PMCID: PMC5814107
Egleston BL, Pedraza O, Wong YN, Dunbrack RL, Griffin CL, Ross EA, Beck JR. Characteristics of clinical trials that require participants to be fluent in English. Clin Trials. 2015 Dec;12(6):618-26.   PMCID: PMC4643363
Zibelman M, Barth P, Handorf E, Smaldone MC, Kutikov A, Uzzo RG, Bilusic M, Plimack ER, Wong YN, Geynisman DM. A review of interventional clinical trials in renal cell carcinoma: a status report from the ClinicalTrials.gov WebSite. Clin Genitourin Cancer. 2015 Apr;13(2):142-9.
Barta SK, Xue X, Wang D, Lee JY, Kaplan LD, Ribera JM, Oriol A, Spina M, Tirelli U, Boue F, Wilson WH, Wyen C, Dunleavy K, Noy A, Sparano JA. A new prognostic score for AIDS-related lymphomas in the rituximab-era. Haematologica. 2014 Nov;99(11):1731-7.   PMCID: 4222464
Chera BS, Eisbruch A, Murphy BA, Ridge JA, Gavin P, Reeve BB, Bruner DW, Movsas B. Recommended patient-reported core set of symptoms to measure in head and neck cancer treatment trials. Journal of the National Cancer Institute. 2014 Jul;106(7).   PMCID: 4192043
Fleisher L, Ruggieri DG, Miller SM, Manne S, Albrecht T, Buzaglo J, Collins MA, Katz M, Kinzy TG, Liu T, Manning C, Charap ES, Millard J, Miller DM, Poole D, Raivitch S, Roach N, Ross EA, Meropol NJ. Application of best practice approaches for designing decision support tools: the preparatory education about clinical trials (PRE-ACT) study. Patient education and counseling. 2014 Jul;96(1):63-71.   PMCID: PMC4171039
Godwin JL, Zibelman M, Plimack ER, Geynisman DM. Immune checkpoint blockade as a novel immunotherapeutic strategy for renal cell carcinoma: a review of clinical trials. Discov Med. 2014 Dec;18(101):341-50.
Loveland-Jones CE, Ruth K, Sigurdson ER, Egleston BL, Boraas M, Bleicher RJ. Patterns of nodal staging during breast conservation surgery in the medicare patient: will the ACOSOG Z0011 trial change the pattern of care?. Breast Cancer Res Treat. 2014 Feb;143(3):571-7.   PMCID: 4161134
Stanton AL, Morra ME, Diefenbach MA, Miller SM, Slevin Perocchia R, Raich PC, Fleisher L, Wen KY, Tran ZV, Mohamed NE, George R, Bright MA, Marcus AC. Responding to a significant recruitment challenge within three nationwide psychoeducational trials for cancer patients. J Cancer Surviv. 2013 Sep;7(3):392-403.   PMCID: Pmc3737366
Barsevick AM, Cleeland CS, Manning DC, O'Mara AM, Reeve BB, Scott JA, Sloan JA, Ascpro. ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage. 2010 Jun;39(6):1086-99.   PMCID: PMC2909842
Buyyounouski MK. Androgen deprivation therapy in high-risk prostate cancer. Oncology (Williston Park). 2010 Aug;24(9):806, 809.   PMCID: Not NIH funded
Buyyounouski MK, Balter P, Lewis B, D'Ambrosio DJ, Dilling TJ, Miller RC, Schefter T, Tome W, Harris EE, Price RA, Konski AA, Wallner PE. Stereotactic body radiotherapy for early-stage non-small-cell lung cancer: report of the ASTRO Emerging Technology Committee. Int J Radiat Oncol Biol Phys. 2010 Sep;78(1):3-10.   PMCID: No funding
von Mehren M, Watson JC. Perioperative tyrosine kinase inhibitors for GIST: standard ... or an idea that needs further investigation?. Oncology (Williston Park). 2009 Jan;23(1):65-6.   PMCID: PMC 2861343
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Clinical Trials as Topic

Clinical Trials as Topic Male therapy Female United States methods Treatment Outcome therapeutic use Neoplasms pathology Prognosis diagnosis Aged Middle Aged Immunotherapy psychology etiology epidemiology Patient Education as Topic Surveys and Questionnaires Adult Patient Selection Young Adult Internet Decision Making drug therapy surgery Neoplasm Staging immunology National Cancer Institute (US) Antineoplastic Agents mortality Combined Modality Therapy Attitudes Health Knowledge-Practice complications clinical trials HIV Infections minorities Social Stigma aids Patient Participation adverse effects Breast Neoplasms trends Lung Neoplasms Trust prevention & control Focus Groups standards Head and Neck Neoplasms Molecular Targeted Therapy HIV Seropositivity Hiv Prostatic Neoplasms Decision Support Techniques Communication Barriers Non-Small-Cell Lung Carcinoma Urban Population perceptual mapping Perception Factual Databases ethnology Kidney Neoplasms Patient Acceptance of Health Care Sex Factors Neoplasm Metastasis Renal Cell Carcinoma perceptions Motivation Adolescent Minority Groups Hoarseness Viral Load DNA Demethylation Prospective Studies genetics Medicare drug effects Benchmarking Radiotherapy Dosage AIDS-Related Lymphoma physiopathology Radiotherapy minority participation statistics & numerical data Decision aids Deglutition Disorders Papillomavirus Infections Antineoplastic Antimetabolites Gastrointestinal Stromal Tumors Early Intervention (Education) human papillomavirus Health Promotion Case-Control Studies health disparities research Rituximab Protein Kinase Inhibitors Patient Care Team Androgen Antagonists Literacy Antineoplastic Combined Chemotherapy Protocols instrumentation Monoclonal Antibodies-Murine-Derived Biomarkers economics chemically induced Quality of Life organization & administration Self Report Squamous Cell Carcinoma Patients Risk Factors United States Food and Drug Administration CD4 Lymphocyte Count Health Status Facial Pain Xerostomia Decitabine Cardiovascular Diseases Cognitive Therapy Lymphatic Metastasis Movement utilization Disease Management Programmed Cell Death 1 Receptor Recurrence eligibility requirements Azacitidine Lymph Node Excision Indoles Kidney cancer Sentinel Lymph Node Biopsy analogs & derivatives Prostate Tumor Burden analysis Biomarker Monoclonal Antibodies Neoadjuvant Therapy Respiratory-Gated Imaging Techniques Language Clinical trials Respiration Radiosurgery virology Radiologic Technology Risk Pyrimidines Tumor Microenvironment Terminology as Topic
Last updated on Saturday, July 04, 2020